Satsuma Pharmaceuticals, Inc. Annual Income Tax Expense (Benefit) in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Satsuma Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2017 to 2022.
  • Satsuma Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
  • Satsuma Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Satsuma Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
  • Satsuma Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2020 was $0.000, a 100% decline from 2019.
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2023-03-28
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-28
2020 $0 -$1K -100% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 $1K $0 0% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 $1K $0 0% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 $1K Jan 1, 2017 Dec 31, 2017 10-K 2020-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.